Maher Mominah
Papers
2
Total Citations
46
H-Index
2
About
Maher Mominah is a leading figure in the advancement of automated pharmacy technology, with a focused expertise in the robotic compounding of sterile, high-risk medications. His pioneering work directly addresses the critical challenges of safety, accuracy, and efficiency in the preparation of antineoplastic and other small-volume parenteral drugs. Mominah’s most impactful contribution, a three-year performance evaluation of a first-generation chemotherapy-compounding robot (39 citations), provided some of the earliest, real-world evidence on the operational reliability and error-reduction potential of such systems. This landmark study, conducted at a Saudi Arabian hospital, demonstrated that automation could significantly enhance safety protocols for both patients and healthcare workers handling hazardous drugs. Further expanding this field, his subsequent work on a standalone robotic device for batch compounding (7 citations) explored the system’s ability to decrease drug wastage and create a retrievable electronic audit trail, reinforcing the value of automation in achieving operational efficiency. Through these rigorous, practice-changing evaluations, Mominah has established himself as a key voice in the global conversation on the future of sterile compounding, providing essential data that supports the transition from manual to robotic processes in hospital pharmacies.
Research Focus
Key Achievements
Top Papers
- 1A three-year study of a first-generation chemotherapy-compounding robot39 citations · 2015
- 2